Uğur Şahin.
Co-founder of BioNTech
He advanced mRNA-based cancer immunotherapy.
His work helped deliver rapid vaccine solutions.
In 1965, he was born in Turkey.
In 1992, he earned his MD from the University of Cologne in Medicine.
In 2008, he co-founded BioNTech.
1. mRNA immunotherapy, a technology that trains the immune system to fight disease.
2. It supports personalised cancer treatment.
3. It enabled fast development of mRNA vaccines.
His leadership guided BioNTech’s global vaccine response.
His research influenced modern immunology.
He currently serves as CEO and leads research at BioNTech.
Want to know more stories?
Visit Uğur Şahin.